Evidence map›Paper›PMID 28704503›Full record

Observational studyPloS one2017

Role of biomarkers in early infectious complications after lung transplantation.

Borja Suberviola, Luzdivina Rellan, Jordi Riera, Reyes Iranzo, Ascension Garcia Campos, Juan Carlos Robles, Rosario Vicente, Eduardo Miñambres, Miguel Santibanez

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Borja SuberviolaCritical Care Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander, Spain.ORCID http://orcid.org/0000-0001-7047-3661
Luzdivina RellanDepartment of Anesthesiology, Complexo Hospitalario Universitario A Coruna, A Coruna, Spain.
Jordi RieraCritical Care Department, Hospital Vall d'Hebron, Barcelona, Spain.
Reyes IranzoDepartment of Anesthesiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Ascension Garcia CamposDepartment of Anesthesiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Juan Carlos RoblesTransplant Coordination Unit, Hospital Universitario Reina Sofia, Cordoba, Spain.
Rosario VicenteDepartment of Anesthesiology, Hospital Universitario y Politécnico de La Fe, Valencia, Spain.
Eduardo MiñambresCritical Care Department - Transplant Coordination Unit, Hospital Universitario Marques de Valdecilla - IDIVAL, Santander, Spain.
Miguel SantibanezNurse School, Universidad de Cantabria - IDIVAL, Santander, Spain.
Instituto de Investigación Marqués de Valdecilla · ESComplexo Hospitalario Universitario A Coruña · ESHospital Universitari i Politècnic La Fe · ESHospital Universitario 12 De Octubre · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Reina Sofía · ESUniversidad de Cantabria · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfections and primary graft dysfunction are devastating complications in the immediate postoperative period following lung transplantation. Nowadays, reliable diagnostic tools are not available. Biomarkers could improve early infection diagnosis.

methodsMulticentre prospective observational study that included all centres authorized to perform lung transplantation in Spain. Lung infection and/or primary graft dysfunction presentation during study period (first postoperative week) was determined. Biomarkers were measured on ICU admission and daily till ICU discharge or for the following 6 consecutive postoperative days.

resultsWe included 233 patients. Median PCT levels were significantly lower in patients with no infection than in patients with Infection on all follow up days. PCT levels were similar for PGD grades 1 and 2 and increased significantly in grade 3. CRP levels were similar in all groups, and no significant differences were observed at any study time point. In the absence of PGD grade 3, PCT levels above median (0.50 ng/ml on admission or 1.17 ng/ml on day 1) were significantly associated with more than two- and three-fold increase in the risk of infection (adjusted Odds Ratio 2.37, 95% confidence interval 1.06 to 5.30 and 3.44, 95% confidence interval 1.52 to 7.78, respectively).

conclusionsIn the absence of severe primary graft dysfunction, procalcitonin can be useful in detecting infections during the first postoperative week. PGD grade 3 significantly increases PCT levels and interferes with the capacity of PCT as a marker of infection. PCT was superior to CRP in the diagnosis of infection during the study period.

Indexed as

AdultBiomarkersCalcitoninCommunicable DiseasesEarly DiagnosisFemaleHumansLung TransplantationMaleMiddle AgedPostoperative ComplicationsPrimary Graft DysfunctionProspective StudiesBiomarkersCalcitonin

Identifiers

PMID28704503
PMCPMC5509107
OpenAlexW2735852743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.